000 01371 a2200349 4500
005 20250517180837.0
264 0 _c20180815
008 201808s 0 0 eng d
022 _a1130-0108
024 7 _a10.17235/reed.2017.5060/2017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzález Vázquez, Santiago
245 0 0 _aImmune mediated colitis caused by lung cancer treatment with atezolizumab.
_h[electronic resource]
260 _bRevista espanola de enfermedades digestivas
_cDec 2017
300 _a863-864 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xcomplications
650 0 4 _aColitis
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xcomplications
650 0 4 _aMale
700 1 _ade la Riva Onandía, Susana
700 1 _aEcheveste, José Ignacio
700 1 _aMuñoz Navas, Miguel
773 0 _tRevista espanola de enfermedades digestivas
_gvol. 109
_gno. 12
_gp. 863-864
856 4 0 _uhttps://doi.org/10.17235/reed.2017.5060/2017
_zAvailable from publisher's website
999 _c27672287
_d27672287